TOKYO -- Takeda Pharmaceutical has asked the Japanese government to fast-track its application for Moderna's coronavirus vaccine, with plans to begin distribution by June.
Moderna is the third COVID-19 vaccine maker to undergo regulatory review in Japan, after Pfizer and AstraZeneca. Takeda is the one-stop agent for Moderna's vaccine here, handling clinical trials, application filing and distribution.
